Article Versions Notes

Hsu C-K, Su S-C, Chang L-C, Yang K-J, Lee C-C, Hsu H-J, Chen Y-T, Sun C-Y, Wu I-W. Oral Absorbent AST-120 Is Associated with Compositional and Functional Adaptations of Gut Microbiota and Modification of Serum Short and Medium-Chain Fatty Acids in Advanced CKD Patients. Biomedicines. 2022; 10(9):2234. https://doi.org/10.3390/biomedicines10092234

Hsu, Cheng-Kai, Shih-Chi Su, Lun-Ching Chang, Kai-Jie Yang, Chin-Chan Lee, Heng-Jung Hsu, Yih-Ting Chen, Chiao-Yin Sun, and I-Wen Wu. 2022. "Oral Absorbent AST-120 Is Associated with Compositional and Functional Adaptations of Gut Microbiota and Modification of Serum Short and Medium-Chain Fatty Acids in Advanced CKD Patients" Biomedicines 10, no. 9: 2234. https://doi.org/10.3390/biomedicines10092234

Hsu, C. -K., Su, S. -C., Chang, L. -C., Yang, K. -J., Lee, C. -C., Hsu, H. -J., Chen, Y. -T., Sun, C. -Y., & Wu, I. -W. (2022). Oral Absorbent AST-120 Is Associated with Compositional and Functional Adaptations of Gut Microbiota and Modification of Serum Short and Medium-Chain Fatty Acids in Advanced CKD Patients. Biomedicines, 10(9), 2234. https://doi.org/10.3390/biomedicines10092234